New Key Statistics Module, Z-Score and F-Score
NAS:CSCI Key Ratios
| Market Cap $ M | 8.25 |
| Enterprise Value $ M | -10.15 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.49 |
| Price/Sales | 0.91 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 7.00 |
| EPS (TTM) $ | -3.99 |
| Beneish M-Score | -0.3 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.88 |
| EV-to-EBITDA | 1.02 |
| PEG | -- |
| Shares Outstanding M | 3.12 |
| Net Margin (%) | -134.16 |
| Operating Margin % | -164.93 |
| Pre-tax Margin (%) | -152.22 |
| Quick Ratio | 3.05 |
| Current Ratio | 3.46 |
| ROA % (ttm) | -31.01 |
| ROE % (ttm) | -46.99 |
| ROIC % (ttm) | -61.67 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.08 |
CSCI Number of Guru Trades
CSCI Volume of Guru Trades
Gurus Latest Trades with NAS:CSCI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CSCI is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cosciens Biopharma Inc Insider Transactions
No Available Data
News about NAS:CSCI
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers